TY - JOUR
T1 - TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies
AU - Terry, Jefferson
AU - Saito, Tsuyoshi
AU - Subramanian, Subbaya
AU - Ruttan, Cindy
AU - Antonescu, Cristina R.
AU - Goldblum, John R.
AU - Downs-Kelly, Erinn
AU - Corless, Christopher L.
AU - Rubin, Brian P.
AU - Van De Rijn, Matt
AU - Ladanyi, Marc
AU - Nielsen, Torsten O.
N1 - Copyright:
Copyright 2009 Elsevier B.V., All rights reserved.
PY - 2007/2
Y1 - 2007/2
N2 - Synovial sarcoma is a soft tissue malignancy defined by the SYT-SSX fusion oncogene. Demonstration of the t(X;18) by cytogenetics, fluorescence in situ hybridization or reverse-transcriptase polymerase chain reaction has become the gold standard for diagnosis, but practical considerations limit the availability of these methods. Gene expression profiling studies performed by several independent groups have consistently identified TLE1 as an excellent discriminator of synovial sarcoma from other sarcomas, including histologically similar tumors such as malignant peripheral nerve sheath tumor. TLE proteins (human homologues of Groucho) are transcriptional corepressors that inhibit Wnt signaling and other cell fate determination signals, and so have an established role in repressing differentiation. We examined the expression of TLE proteins in synovial sarcoma and in a broad range of mesenchymal tumors using tissue microarrays to assess the value of anti-TLE antibodies in the immunohistochemical confirmation of synovial sarcoma. We demonstrate that TLE expression is a consistent feature of synovial sarcoma using both a well-characterized monoclonal antibody recognizing the TLE family of proteins and a commercially available polyclonal antibody raised against TLE1. Both antibodies gave intense and/or diffuse nuclear staining in 91/94 molecularly confirmed synovial sarcomas. Moderate staining is occasionally seen in schwannoma and solitary fibrous tumor/hemangiopericytoma. In contrast, TLE staining is detected much less frequently and at lower levels, if at all, in 40 other mesenchymal tumors. Our findings establish TLE as a robust immunohistochemical marker for synovial sarcoma, and may have implications for understanding the biology of synovial sarcoma and for developing experimental therapies for this cancer.
AB - Synovial sarcoma is a soft tissue malignancy defined by the SYT-SSX fusion oncogene. Demonstration of the t(X;18) by cytogenetics, fluorescence in situ hybridization or reverse-transcriptase polymerase chain reaction has become the gold standard for diagnosis, but practical considerations limit the availability of these methods. Gene expression profiling studies performed by several independent groups have consistently identified TLE1 as an excellent discriminator of synovial sarcoma from other sarcomas, including histologically similar tumors such as malignant peripheral nerve sheath tumor. TLE proteins (human homologues of Groucho) are transcriptional corepressors that inhibit Wnt signaling and other cell fate determination signals, and so have an established role in repressing differentiation. We examined the expression of TLE proteins in synovial sarcoma and in a broad range of mesenchymal tumors using tissue microarrays to assess the value of anti-TLE antibodies in the immunohistochemical confirmation of synovial sarcoma. We demonstrate that TLE expression is a consistent feature of synovial sarcoma using both a well-characterized monoclonal antibody recognizing the TLE family of proteins and a commercially available polyclonal antibody raised against TLE1. Both antibodies gave intense and/or diffuse nuclear staining in 91/94 molecularly confirmed synovial sarcomas. Moderate staining is occasionally seen in schwannoma and solitary fibrous tumor/hemangiopericytoma. In contrast, TLE staining is detected much less frequently and at lower levels, if at all, in 40 other mesenchymal tumors. Our findings establish TLE as a robust immunohistochemical marker for synovial sarcoma, and may have implications for understanding the biology of synovial sarcoma and for developing experimental therapies for this cancer.
KW - Expression profiling
KW - Immunohistochemistry
KW - Microarray
KW - Synovial sarcoma
KW - TLE
UR - http://www.scopus.com/inward/record.url?scp=33846581975&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33846581975&partnerID=8YFLogxK
U2 - 10.1097/01.pas.0000213330.71745.39
DO - 10.1097/01.pas.0000213330.71745.39
M3 - Article
C2 - 17255769
AN - SCOPUS:33846581975
SN - 0147-5185
VL - 31
SP - 240
EP - 246
JO - American Journal of Surgical Pathology
JF - American Journal of Surgical Pathology
IS - 2
ER -